Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Gene Marking in Adeno-Associated Virus Vector Infected Periosteum Derived Cells for Cartilage Repair

NAOMI KOBAYASHI, TOMIHISA KOSHINO, MASAAKI UESUGI, NAOKI YOKOO, KE-QIN XIN, KENJI OKUDA, HIROAKI MIZUKAMI, KEIYA OZAWA, and TOMOYUKI SAITO

ABSTRACT.

Objective.
To evaluate both the potential for transferring genes to periosteal cells using an adeno-associated virus (AAV) vector and the potential for gene expression after transplantation of those cells to a cartilage defect in vivo.

Methods. Periosteum was obtained from the tibia of 6-week-old rabbits and enzymatically digested. The isolated periosteum derived cells were cultured and the subconfluence cells were infected with a recombinant AAV expressing the LacZ gene (AAV-LacZ). Collagen gel containing the LacZ transferred, periosteum derived cells was transplanted into a full thickness articular cartilage defect in 10 rabbits.

Results. Infected cells still growing on the plate continued to express LacZ at least 12 weeks after AAV infection, with the highest percentage of LacZ positive cells reaching 74.4%. The LacZ positive cells were recognized at the transplant sites in 8 out of 10 knees.

Conclusion. Gene expression in periosteum derived cells was sustained in vitro for at least 12 weeks using the AAV vector, and for 2 weeks ex vivo after transplantation into a cartilage defect. (J Rheumatol 2002;29:2176-80)

Key Indexing Terms:

ADENO-ASSOCIATED VIRUS
LACZ GENE
PERIOSTEUM DERIVED CELLS
CARTILAGE


From the Departments of Orthopaedic Surgery and Bacteriology, Yokohama City University School of Medicine, Yokohama; and Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yokohama, Japan.

Supported by a Grant-in-Aid from the Ministry of Education, Science, Sports, and Culture of Japan.

N. Kobayashi, MD; T. Koshino, MD, PhD; M. Uesugi, MD, PhD; N. Yokoo, MD, Department of Orthopaedic Surgery; K. Xin, MD, PhD; K. Okuda, MD, PhD, Department of Bacteriology, Yokohama City University School of Medicine; H. Mizukami, MD, PhD; K. Ozawa, MD, PhD, Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School; T. Saito, MD, PhD, Department of Orthopaedic Surgery, Yokohama City University School of Medicine.

Address reprint requests to Dr. N. Kobayashi, Department of Orthopaedic Surgery, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. E-mail: naomik@ea.mbn.or.jp

Submitted August 13, 2001; revision accepted April 24, 2002.




Return to October 2002 Table of Contents



© 2002. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.